Published in Stroke on July 22, 2010
Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage | NCT02367248
Etiology and Prognostic Risk Factors of Intracerebral Hemorrhage in Beijing | NCT02350010
Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage (FITCH) | NCT04088630
Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care (2013) 3.65
Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol (2012) 2.62
Individual patient data subgroup meta-analysis of surgery for spontaneous supratentorial intracerebral hemorrhage. Stroke (2012) 2.26
Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage. Ann Neurol (2015) 1.99
Surveillance neuroimaging and neurologic examinations affect care for intracerebral hemorrhage. Neurology (2013) 1.90
Wide variation and rising utilization of stroke magnetic resonance imaging: data from 11 states. Ann Neurol (2012) 1.76
Racial disparities in methamphetamine-associated intracerebral hemorrhage. Neurology (2015) 1.63
Racial disparities among Native Hawaiians and Pacific Islanders with intracerebral hemorrhage. Neurology (2012) 1.60
Predictors of 30-day readmission after intracerebral hemorrhage: a single-center approach for identifying potentially modifiable associations with readmission. Crit Care Med (2013) 1.52
Integrating Palliative Care Into the Care of Neurocritically Ill Patients: A Report From the Improving Palliative Care in the ICU Project Advisory Board and the Center to Advance Palliative Care. Crit Care Med (2015) 1.50
Impact of advanced healthcare directives on treatment decisions by physicians in patients with acute stroke. Crit Care Med (2013) 1.44
Neurology and neurologic practice in China. Neurology (2011) 1.43
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care (2016) 1.43
Microglial responses after ischemic stroke and intracerebral hemorrhage. Clin Dev Immunol (2013) 1.43
Intraventricular hemorrhage expansion in patients with spontaneous intracerebral hemorrhage. Neurology (2015) 1.42
Clinical predictors of seizure recurrence after the first post-ischemic stroke seizure. BMC Neurol (2016) 1.39
Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke (2013) 1.34
Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med (2015) 1.29
Decompressive craniectomy: past, present and future. Nat Rev Neurol (2013) 1.24
Delayed intraventricular hemorrhage is common and worsens outcomes in intracerebral hemorrhage. Neurology (2013) 1.24
Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document". Blood Transfus (2013) 1.23
Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy. Neurology (2013) 1.20
Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage. Ann Neurol (2011) 1.11
Neuroinflammation after intracerebral hemorrhage. Front Cell Neurosci (2014) 1.05
Peripheral monocyte count is associated with case fatality after intracerebral hemorrhage. J Stroke Cerebrovasc Dis (2013) 1.04
Progress in translational research on intracerebral hemorrhage: is there an end in sight? Prog Neurobiol (2013) 1.03
Poor long-term blood pressure control after intracerebral hemorrhage. Stroke (2012) 1.02
Symptomatic and palliative care for stroke survivors. J Gen Intern Med (2012) 1.02
Experimental intracerebral hemorrhage: avoiding pitfalls in translational research. J Cereb Blood Flow Metab (2011) 1.02
Clinician judgment vs formal scales for predicting intracerebral hemorrhage outcomes. Neurology (2015) 0.98
A critical appraisal of experimental intracerebral hemorrhage research. J Cereb Blood Flow Metab (2012) 0.97
Estimating and communicating prognosis in advanced neurologic disease. Neurology (2013) 0.96
Dynamic cerebral autoregulation after intracerebral hemorrhage: A case-control study. BMC Neurol (2011) 0.96
Early do-not-resuscitate orders in intracerebral haemorrhage; frequency and predictive value for death and functional outcome. A retrospective cohort study. Scand J Trauma Resusc Emerg Med (2012) 0.95
Swirl sign in intracerebral haemorrhage: definition, prevalence, reliability and prognostic value. BMC Neurol (2012) 0.94
An association between systolic blood pressure and stroke among patients with impaired consciousness in out-of-hospital emergency settings. BMC Emerg Med (2013) 0.94
Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment. JAMA Neurol (2014) 0.93
Coagulation assessment with the new generation of oral anticoagulants. Emerg Med J (2015) 0.93
Prehospital stroke care: new prospects for treatment and clinical research. Neurology (2013) 0.92
Simultaneous detection and separation of hyperacute intracerebral hemorrhage and cerebral ischemia using amide proton transfer MRI. Magn Reson Med (2015) 0.91
Brain perihematoma genomic profile following spontaneous human intracerebral hemorrhage. PLoS One (2011) 0.91
Prophylactic Antiepileptic Drug Use and Outcome in the Ethnic/Racial Variations of Intracerebral Hemorrhage Study. Stroke (2015) 0.91
Promoting blood circulation for removing blood stasis therapy for acute intracerebral hemorrhage: a systematic review and meta-analysis. Acta Pharmacol Sin (2015) 0.90
Factors associated with early deterioration after spontaneous intracerebral hemorrhage: a systematic review and meta-analysis. PLoS One (2014) 0.90
Advances in the management of intracerebral hemorrhage. J Neural Transm (Vienna) (2013) 0.90
Magnetic resonance imaging profile of blood-brain barrier injury in patients with acute intracerebral hemorrhage. J Am Heart Assoc (2013) 0.89
Treatment targets in intracerebral hemorrhage. Neurotherapeutics (2011) 0.89
Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study. J Neurol (2013) 0.89
The role of the microglia in acute CNS injury. Metab Brain Dis (2014) 0.88
Transcranial MRI-Guided Focused Ultrasound: A Review of the Technologic and Neurologic Applications. AJR Am J Roentgenol (2015) 0.88
Multimodality monitoring for cerebral perfusion pressure optimization in comatose patients with intracerebral hemorrhage. Stroke (2011) 0.87
European research priorities for intracerebral haemorrhage. Cerebrovasc Dis (2011) 0.87
Intracranial hemorrhage. Am J Respir Crit Care Med (2011) 0.86
Gender and age interact to affect early outcome after intracerebral hemorrhage. PLoS One (2013) 0.86
Managing acute stroke in low-resource settings. Bull World Health Organ (2016) 0.86
Liraglutide, a long-acting GLP-1 mimetic, and its metabolite attenuate inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab (2012) 0.85
Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke. World J Clin Cases (2015) 0.85
Therapeutic strategies in acute intracerebral hemorrhage. Neurotherapeutics (2012) 0.85
Modulating the Immune Response Towards a Neuroregenerative Peri-injury Milieu After Cerebral Hemorrhage. J Neuroimmune Pharmacol (2015) 0.84
Perihematomal edema as predictor of outcome in spontaneous intracerebral hemorrhage. J Neurosci Rural Pract (2014) 0.84
Fate of diffusion restricted lesions in acute intracerebral hemorrhage. PLoS One (2014) 0.84
Management of non-traumatic intraventricular hemorrhage. Neurosurg Rev (2012) 0.84
The accuracy of spot sign in predicting hematoma expansion after intracerebral hemorrhage: a systematic review and meta-analysis. PLoS One (2014) 0.83
Can minimally invasive puncture and drainage for hypertensive spontaneous Basal Ganglia intracerebral hemorrhage improve patient outcome: a prospective non-randomized comparative study. Mil Med Res (2014) 0.83
How I treat and manage strokes in sickle cell disease. Blood (2015) 0.83
Cost-effectiveness of transfers to centers with neurological intensive care units after intracerebral hemorrhage. Stroke (2014) 0.83
Clinical use and the Italian demand for prothrombin complex concentrates. Blood Transfus (2013) 0.83
Full medical support for intracerebral hemorrhage. Neurology (2015) 0.83
The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease. Expert Rev Hematol (2011) 0.82
Contemporary clinical management of the cerebral complications of preeclampsia. Obstet Gynecol Int (2013) 0.82
Declining rates of fatal and nonfatal intracerebral hemorrhage: epidemiological trends in Australia. J Am Heart Assoc (2014) 0.82
Temporal changes in perihematomal apparent diffusion coefficient values during the transition from acute to subacute phases in patients with spontaneous intracerebral hemorrhage. Neuroradiology (2012) 0.81
Intra-arterial therapy for acute ischemic stroke. Neurotherapeutics (2011) 0.81
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal. Crit Care (2013) 0.81
Lowering of blood pressure for recurrent stroke prevention. Stroke (2014) 0.81
Magnetic resonance imaging versus computed tomography for identification and quantification of intraventricular hemorrhage. J Stroke Cerebrovasc Dis (2014) 0.81
Blood pressure at hospital admission and outcome after primary intracerebral hemorrhage. Arch Med Sci (2013) 0.81
Perioperative management of coagulation in nontraumatic intracerebral hemorrhage. Anesthesiology (2013) 0.81
Advances in our Understanding of the Pathophysiology, Detection and Management of Cerebral Amyloid Angiopathy. Eur Neurol Rev (2012) 0.81
Intracerebral hemorrhage: toward physiological imaging of hemorrhage risk in acute and chronic bleeding. Front Neurol (2012) 0.80
Optimal cerebral perfusion pressure in patients with intracerebral hemorrhage: an observational case series. Crit Care (2014) 0.80
The definition of a prolonged intensive care unit stay for spontaneous intracerebral hemorrhage patients: an application with national health insurance research database. Biomed Res Int (2014) 0.80
Interrupting anticoagulation in patients with nonvalvular atrial fibrillation. P T (2014) 0.80
Outcomes after stroke complicating left ventricular assist device. J Heart Lung Transplant (2016) 0.80
Clopidogrel use is associated with an increased prevalence of cerebral microbleeds in a stroke-free population: the Rotterdam study. J Am Heart Assoc (2013) 0.80
Evolving use of seizure medications after intracerebral hemorrhage: A multicenter study. Neurology (2016) 0.80
Diagnosis and Management of Acute Intracerebral Hemorrhage. Emerg Med Clin North Am (2016) 0.80
2013 Korean Society of Hypertension guidelines for the management of hypertension: part III-hypertension in special situations. Clin Hypertens (2015) 0.79
Predicting Intracerebral Hemorrhage Growth With the Spot Sign: The Effect of Onset-to-Scan Time. Stroke (2016) 0.79
Association of age and admission mean arterial blood pressure in patients with stroke-data from a national stroke registry. Hypertens Res (2016) 0.79
Outcomes in children with hemorrhagic stroke. JAMA Neurol (2013) 0.79
Renal dysfunction is associated with deep cerebral microbleeds but not white matter hyperintensities in patients with acute intracerebral hemorrhage. J Neurol (2015) 0.79
New trends in hyperosmolar therapy? Curr Opin Crit Care (2013) 0.79
Mechanical ventilation for comatose patients with inoperative acute intracerebral hemorrhage: possible futility of treatment. PLoS One (2014) 0.79
Blood Pressure Management After Intracerebral Hemorrhage. Curr Treat Options Neurol (2015) 0.79
Secondary stroke prevention: challenges and solutions. Vasc Health Risk Manag (2015) 0.79
Leakage Sign for Primary Intracerebral Hemorrhage: A Novel Predictor of Hematoma Growth. Stroke (2016) 0.79
Prehospital systolic blood pressure is higher in acute stroke compared with stroke mimics. Neurology (2016) 0.78
Current management of intracerebral haemorrhage in China: a national, multi-centre, hospital register study. BMC Neurol (2011) 0.78
Minimally invasive endoscopic surgery for treatment of spontaneous intracerebral haematomas. Neurosurg Rev (2015) 0.78
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Intensive insulin therapy in critically ill patients. N Engl J Med (2001) 40.00
Intensive versus conventional glucose control in critically ill patients. N Engl J Med (2009) 26.30
Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med (2009) 11.49
Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2005) 9.58
The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke (2001) 8.73
Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet (2007) 8.68
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.94
Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke (1993) 6.94
Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev (2007) 5.93
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2008) 5.77
Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation. BMJ (2001) 5.77
Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol (2008) 5.40
Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology (2006) 4.88
Cerebral amyloid angiopathy. A critical review. Stroke (1987) 4.56
Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke (1997) 4.55
Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology (2007) 4.22
Blood pressure and clinical outcomes in the International Stroke Trial. Stroke (2002) 3.94
Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology (2007) 3.73
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med (2004) 3.63
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology (2007) 3.56
CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke (2007) 3.43
Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke (2002) 3.43
Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology (2007) 3.38
Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med (2001) 3.24
Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med (2000) 3.23
Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology (2004) 3.21
Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke (2003) 3.12
Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke (2004) 3.07
Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology (2001) 3.07
Guidelines on oral anticoagulation (warfarin): third edition--2005 update. Br J Haematol (2006) 3.03
The impact of hospital nursing characteristics on 30-day mortality. Nurs Res (2005) 3.02
Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke (2004) 2.92
Grading scale for prediction of outcome in primary intracerebral hemorrhages. Stroke (2007) 2.85
Prospective validation of the ICH Score for 12-month functional outcome. Neurology (2009) 2.84
Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust (2004) 2.74
Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke (2008) 2.72
Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke (2003) 2.71
Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage. AJNR Am J Neuroradiol (2007) 2.69
Is this patient having a stroke? JAMA (2005) 2.69
Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med (1999) 2.65
Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med (2008) 2.57
High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension (2003) 2.52
Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury. Crit Care Med (2006) 2.43
Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke (2004) 2.42
Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg (2002) 2.40
Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol (1971) 2.35
Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg (2004) 2.31
Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology (2003) 2.29
Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke (1999) 2.28
Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol (2008) 2.27
Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology (2009) 2.23
Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol (1991) 2.20
The treatment of spontaneous intracerebral hemorrhage. A prospective randomized trial of surgical and conservative treatment. J Neurosurg (1989) 2.20
Seizures after stroke: a prospective multicenter study. Arch Neurol (2000) 2.18
The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology (2007) 2.13
Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke (2009) 1.96
Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J Biol Chem (2005) 1.95
Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke (1999) 1.94
Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis (2006) 1.91
Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke (2007) 1.90
Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg (1989) 1.89
Antiplatelet use after intracerebral hemorrhage. Neurology (2006) 1.88
Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg (1985) 1.87
Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A (2009) 1.83
Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke (2005) 1.83
Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial. Acta Neurochir Suppl (2006) 1.81
Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost (2008) 1.81
Racial variations in location and risk of intracerebral hemorrhage. Stroke (2005) 1.78
Management of spontaneous cerebellar hematomas: a prospective treatment protocol. Neurosurgery (2001) 1.77
Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke (2003) 1.76
Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets. Stroke (2009) 1.72
Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke (2008) 1.72
Practical limitations of acute stroke MRI due to patient-related problems. Neurology (2004) 1.71
Recurrence of bleeding in patients with primary intracerebral hemorrhage. Stroke (1995) 1.71
A prospective randomized study to determine the optimal dose of intravenous vitamin K in reversal of over-warfarinization. Br J Haematol (2000) 1.70
Immunotherapy reduces vascular amyloid-beta in PDAPP mice. J Neurosci (2008) 1.70
Use of the original, modified, or new intracerebral hemorrhage score to predict mortality and morbidity after intracerebral hemorrhage. Stroke (2003) 1.69
Guidelines for the management of severe traumatic brain injury. IX. Cerebral perfusion thresholds. J Neurotrauma (2007) 1.67
Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage. J Neurol Sci (2007) 1.67
U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med (2004) 1.67
Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats. Stroke (2009) 1.65
Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med (2007) 1.63
Frequency of sustained intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Cerebrovasc Dis (2009) 1.63
Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology (2000) 1.62
Camino intracranial pressure monitor: prospective study of accuracy and complications. J Neurol Neurosurg Psychiatry (2000) 1.62
Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial. Acta Neurochir Suppl (2008) 1.59
Postcontrast CT extravasation is associated with hematoma expansion in CTA spot negative patients. Stroke (2009) 1.58
Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke (1998) 1.58
Priorities for clinical research in intracerebral hemorrhage: report from a National Institute of Neurological Disorders and Stroke workshop. Stroke (2005) 1.58
Impact of a neuroscience intensive care unit on neurosurgical patient outcomes and cost of care: evidence-based support for an intensivist-directed specialty ICU model of care. J Neurosurg Anesthesiol (2001) 1.57
Surgical treatment for intracerebral hemorrhage (STICH): a single-center, randomized clinical trial. Neurology (1998) 1.56
Predictors and outcome of seizures after spontaneous intracerebral hemorrhage. Clinical article. J Neurosurg (2009) 1.55
Advance hospital notification by EMS in acute stroke is associated with shorter door-to-computed tomography time and increased likelihood of administration of tissue-plasminogen activator. Prehosp Emerg Care (2008) 1.54
Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04
Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med (2008) 19.76
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 12.92
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007) 8.03
Bioethical considerations in translational research: primate stroke. Am J Bioeth (2009) 7.21
Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol (2008) 5.40
Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology (2007) 4.22
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke. Ann Emerg Med (2005) 4.04
Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol (2007) 3.83
Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke (2005) 3.67
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med (2004) 3.63
Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology (2012) 3.62
Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med (2007) 3.61
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Early supported discharge services for stroke patients: a meta-analysis of individual patients' data. Lancet (2005) 3.56
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation. Ann Intern Med (2009) 3.44
Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke (2002) 3.43
National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke (2008) 3.40
Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke (2002) 3.36
Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2014) 3.36
Designing a message for public education regarding stroke: does FAST capture enough stroke? Stroke (2007) 3.34
The minipterional craniotomy for anterior circulation aneurysms: initial experience with 72 patients. Neurosurgery (2014) 3.26
National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline. Ann Intern Med (2010) 3.24
Intensive care unit quality improvement: a "how-to" guide for the interdisciplinary team. Crit Care Med (2006) 3.15
Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke (2003) 3.12
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med (2004) 3.06
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med (2003) 3.02
Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke (2005) 3.00
Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol (2009) 2.98
Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke (2004) 2.97
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis (2006) 2.96
Methodology of the Interventional Management of Stroke III Trial. Int J Stroke (2008) 2.88
Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol (2005) 2.85
Inflammation in stroke and focal cerebral ischemia. Surg Neurol (2006) 2.85
Cerebral amyloid angiopathy in the elderly. Ann Neurol (2011) 2.84
Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care (2011) 2.81
Stroke among patients with dizziness, vertigo, and imbalance in the emergency department: a population-based study. Stroke (2006) 2.73
Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke (2008) 2.72
Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med (2006) 2.58
Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery (2009) 2.58
Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med (2008) 2.57
Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke (2005) 2.49
Neurological, functional, and cognitive stroke outcomes in Mexican Americans. Stroke (2014) 2.48
Current status of endovascular stroke treatment. Circulation (2011) 2.42
Trends in community knowledge of the warning signs and risk factors for stroke. JAMA (2003) 2.40
Disconnection of the ascending arousal system in traumatic coma. J Neuropathol Exp Neurol (2013) 2.38
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38
Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens (2006) 2.37
Designing multi-ethnic stroke studies: the Brain Attack Surveillance in Corpus Christi (BASIC) project. Ethn Dis (2004) 2.37
Perimesencephalic subarachnoid hemorrhage: incidence, risk factors, and outcome. J Stroke Cerebrovasc Dis (2007) 2.36
Rates of pediatric injuries by 3-month intervals for children 0 to 3 years of age. Pediatrics (2003) 2.35
Brain tissue oxygen tension is more indicative of oxygen diffusion than oxygen delivery and metabolism in patients with traumatic brain injury. Crit Care Med (2008) 2.34
Neuropsychological dysfunction in the absence of structural evidence for cerebral ischemia after uncomplicated carotid endarterectomy. Neurosurgery (2006) 2.33
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol (2010) 2.31
Cerebral microinfarcts: the invisible lesions. Lancet Neurol (2012) 2.31
Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol (2013) 2.29
Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke (2009) 2.28
Concealed neuroanatomy in Michelangelo's Separation of Light From Darkness in the Sistine Chapel. Neurosurgery (2010) 2.27
Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke (2005) 2.26
Individual patient data subgroup meta-analysis of surgery for spontaneous supratentorial intracerebral hemorrhage. Stroke (2012) 2.26
ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci (2002) 2.25
Confounding by indication in retrospective studies of intracerebral hemorrhage: antiepileptic treatment and mortality. Neurocrit Care (2012) 2.25
Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial. BMJ (2012) 2.23
Falling temperature and colder weather are associated with an increased risk of aneurysmal subarachnoid hemorrhage. World Neurosurg (2012) 2.20
Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab (2006) 2.20
NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline. NIH Consens State Sci Statements (2010) 2.19
Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes (2010) 2.17
External ventricular drainage following aneurysmal subarachnoid haemorrhage. Br J Neurosurg (2010) 2.15
Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke (2002) 2.13
Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration. Heart Rhythm (2006) 2.13
Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke (2008) 2.12
Intracranial infectious aneurysms: a comprehensive review. Neurosurg Rev (2009) 2.11
Intracranial hemorrhage associated with revascularization therapies. Stroke (2007) 2.08
Craniofacial resection of midline anterior skull base malignancies: a reassessment of outcomes in the modern era. World Neurosurg (2011) 2.08
Acute care clinical indicators associated with discharge outcomes in children with severe traumatic brain injury. Crit Care Med (2014) 2.04
Stroke risk after nonstroke emergency department dizziness presentations: a population-based cohort study. Ann Neurol (2014) 2.02
Early reperfusion and clinical outcomes in patients with M2 occlusion: pooled analysis of the PROACT II, IMS, and IMS II studies. J Neurosurg (2014) 2.01